tirzepatide in europe EU drug regulator to review Lilly's Mounjaro multi-dose pen Lilly's Mounjaro Fails to Win

Description

The FDA states while its legal for companies to make Semaglutide, the FDA does not evaluate the safety, effectiveness, or quality of compounded drug products before such drugs are marketed. Drug manufacturer Novo Nordisk is warning of counterfeits that look very similar to theirs, but they say these could pose the risk of serious adverse effects

Bull, J

However, researchers emphasize the need for larger trials

Without clinical data, there is no way to predict which group you fall into before trying

Este medicamento puede causar efectos secundarios, como nuseas y vmitos, cambios en las deposiciones, como diarrea o estreimiento, dolor abdominal, dolor de cabeza y fatiga